Eli Lilly Tries To Nix Claims In Mounjaro Failure-To-Warn Suit
The maker of a medication for treating diabetes says a suit over its alleged failure to warn a patient about the risk of severe stomach issues is stymied by clear disclosure...To view the full article, register now.
Already a subscriber? Click here to view full article